REFERENCES
- Ahuja A, Khar R. K., Ali J. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 1997; 23: 489–515, [CSA]
- Birudaraj R., Mahalingam R., Li X., Jasti B. R. Advances in Buccal Drug Delivery. Critical Reviews in Therapeutic Drug Carrier Systems 2005; 22: 295–330, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chun M.-K., Kwak B.-T., Choi H.-K. Preparation of buccal patch composed of carbopol, poloxamer, and hydroxypropyl methylcellulose. Arch. Pharm. Res. 2003; 26: 973–978, [PUBMED], [INFOTRIEVE], [CSA]
- deVries M. E., Bodde H. E., Busscher H. J., Junginger H. E. Hydrogels for buccal drug delivery: properties relevant for muco-adhesion. J. Biomed. Mat. Res. 1988; 22: 1023–1032, [CSA], [CROSSREF]
- deVries M. E., Bodde H. E., Verhoef J., Junginger H. E. Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1991; 8: 271–303, [CSA]
- Gupta P. K., Leung S.-H. S., Robinson J. R. Bioadhesives/mucoadhesives in drug delivery to the gastrointestinal tract. Bioadhesive Drug Delivery Systems, V. Lenaerts, R. Gurny. Informa UK Ltd, Boca Raton, FL 1990; 65–92
- Harris D., Robinson J. R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992; 81: 1–10, [PUBMED], [INFOTRIEVE], [CSA]
- Ikinci G., Capan Y., Senel S., Alaaddinoglu E., Dalkara T., Hincal A. A. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie 2000; 55: 762–765, [PUBMED], [INFOTRIEVE], [CSA]
- Ishida M., Machida Y., Nambu N., Nagai T. New mucosal dosage form of insulin. Chem. Pharm. Bull. (Tokyo) 1981; 29: 810–816, [CSA]
- Knuth K., Amiji M., Robinson J. R. Hydrogel delivery systems for vaginal and oral applications: formulation and biological considerations. Adv. Drug Del. Rev. 1993; 11: 137–167, [CSA], [CROSSREF]
- Lee J. W., Park J. H., Robinson J. R. Bioadhesive based dosage forms: the next generation. J. Pharm. Sci. 2000; 89: 850–866, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lehr C. M., Bouwstra J. A., Spies F., Onderwater J., van het Noordeinde J., Vermeij-Keers C., van Munsteren C. J., Junginger H. E. Visualization studies of the mucoadhesion interface. J. Control. Rel. 1992; 18: 249–260, [CSA], [CROSSREF]
- Miyazaki S., Kawasaki N., Nakamura T., Iwatsu M., Hayashi T., Hou W. M., Attwood D. Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and in vivo evaluation. International Journal of Pharmaceutics 2000; 204: 127–132, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mortazavi S. A., Smart J. D. Factors influencing gel-strengthening at the mucoadhesive-mucus interface. J. Pharm. Pharmacol. 1994; 46: 86–90, [PUBMED], [INFOTRIEVE], [CSA]
- http://www.pharma.noveoninc.com/literature/bulletin/epb16.pdf Noveon Product Info. Pharmaceutical Polymers Bulletin 16: Bioadhesion. Noveon, Inc.
- Park H., Robinson J. R. Physicochemical properties of water-insoluble polymers important to mucin/epithelial adhesion. J. Control. Rel. 1985; 2: 47–57, [CSA], [CROSSREF]
- Peppas N. A., Buri P. A. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Rel. 1985; 2: 257–275, [CSA], [CROSSREF]
- Peppas N. A., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Euro. J. Pharm. Biopharm. 2000; 50: 27–046, [CSA], [CROSSREF]
- Ponchel G., Lejoyeux F., Duchene D. Bioadhesion of poly(acrylic acid) containing systems. Thermodynamics and rheological aspects. Proc. Int. Sym. Cont. Rel. Bioact. Mater. 1991; 18: 111–112, [CSA]
- Ponchel G., Touchard F., Duchene D., Peppas N. A. Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly(acrylic acid) containing systems. J. Control. Rel. 1987; 5: 129–141, [CSA], [CROSSREF]
- Ponchel G., Touchard F., Wouessidjewe D., Duchene D., Peppas N. A. Bioadhesive analysis of controlled-release systems. III. Bioadhesive and release behavior of metronidazole containing poly(acrylic acid)–hydroxypropyl methylcellulose systems. Int. J. Pharm. 1987; 38: 65–70, [CSA], [CROSSREF]
- Rathbone M. J., Ponchel G., Ghazali F. Systemic oral mucosal drug delivery. Oral Mucosal Drug Delivery, M. J. Rathbone. Informa UK Ltd, New York 1996; 241
- Raz I., Ben-David J., Hussein Z., Samara E. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects. Int. J. Clin. Pharmacol. Ther. Toxicol. 1988; 26: 206–208, [PUBMED], [INFOTRIEVE], [CSA]
- Smart J. D. Some formulation factors influencing the rate of drug release from bioadhesive matrices. Drug Dev. Ind. Pharm. 1992; 18: 223–232, [CSA]
- Smart J. D. Recent Developments in the Use of Bioadhesive Systems for Delivery of Drugs to the Oral Cavity. Critical Reviews in Therapeutic Drug Carrier Systems 2004; 21: 319–344, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smart J. D., Kellaway I. W., Worthington H. E. C. An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol. 1984; 36: 295–299, [PUBMED], [INFOTRIEVE], [CSA]
- Srinivasu P., Rambhau D., Rao B. R., Rao Y. M. Pharmacokinetics of pentoxifylline after oral administration of a sustained release tablet at two different times of a day. Arzneim.-Forsch./ Drug Res. 1999; 49: 750–753, [CSA]
- Tamburic S., Craig. D. Q. M. A comparison of different in vitro methods for measuring mucoadhesive performance. Eur. J. Pharm. Biopharm. 1997; 44: 159–167, [CSA], [CROSSREF]
- The Merck Index, 12th edition, Merck & Co., Inc. (1996), 1228
- Tobyn M. J., Johnson J. R., Dettmar P. W. Factors affecting in vitro gastric mucoadhesion. I. Test conditions and instrumental parameters. Eur. J. Pharm. Biopharm. 1995; 41: 235–241, [CSA]
- Tsuchida E., Abe K. Interactions between macromolecules in solution and intermolecular complexes. Advances in Polymer Sciences 1982; 45: 1–130, [CSA]